Weak Opioid / Serotonin-Noradrenaline Reuptake Inhibitor (Analgesic)
Pregnancy: Caution — neonatal withdrawal if used near term; avoid prolonged use
Tramadol (Post-Operative Pain)
Brand names: Tramacet (tramadol/paracetamol combination), Zydol, Tramadol hydrochloride
Adult dose
Dose: 50–100 mg oral or IV/IM every 4–6 hours
Route: Oral, IV slow injection, or IM
Frequency: Every 4–6 hours
Max: 400 mg/day (oral or IV)
IV: dilute in 100 mL NaCl 0.9% and infuse over 15–20 min (slow IV reduces nausea/seizure risk). Suitable for moderate-severe post-operative pain as part of multimodal analgesia regimen.
Paediatric dose
Dose: 1 mg/kg
Route: Oral or IV
Frequency: Every 4–6 hours
Max: 400 mg/day
Concentration: 50 mg/mL (injectable) mg/ml
Children ≥12 years: adult doses. Avoid in children <12 years (MHRA warning — respiratory depression risk, especially post-tonsillectomy). Ultra-rapid CYP2D6 metabolisers at higher risk.
Dose adjustments
Renal
Reduce dose and frequency in renal impairment (eGFR 10–30: 50 mg every 12h max; avoid if eGFR <10)
Hepatic
Reduce dose and frequency in hepatic impairment
Paediatric weight-based calculator
Children ≥12 years: adult doses. Avoid in children <12 years (MHRA warning — respiratory depression risk, especially post-tonsillectomy). Ultra-rapid CYP2D6 metabolisers at higher risk.
Clinical pearls
- MHRA 2013: avoid tramadol in children <12 years — risk of respiratory depression, especially ultra-rapid CYP2D6 metabolisers after tonsillectomy
- Serotonin syndrome risk: significant with SSRIs/SNRIs — common combination in surgical patients on antidepressants; monitor for agitation, hyperthermia, clonus
- Not interchangeable 1:1 with codeine — tramadol has serotonergic mechanism in addition to weak opioid activity
- Epilepsy: tramadol lowers seizure threshold — avoid or use with extreme caution
- Antiemetic prophylaxis: nausea is very common with tramadol — always co-prescribe antiemetic
Contraindications
- MAOI use (within 14 days — serotonin syndrome)
- Acute intoxication with alcohol, opioids, or psychotropics
- Severe renal or hepatic impairment
- Uncontrolled epilepsy
- Children <12 years (MHRA)
Side effects
- Nausea and vomiting (common — co-prescribe antiemetic)
- Dizziness and sedation
- Seizures (lowers seizure threshold)
- Constipation
- Serotonin syndrome (with SSRIs/SNRIs/MAOIs)
- Respiratory depression (lower risk than strong opioids)
Interactions
- MAOIs — serotonin syndrome (contraindicated; 14-day washout)
- SSRIs/SNRIs/TCAs — serotonin syndrome risk (monitor closely)
- Ondansetron — serotonin syndrome risk (also reduces tramadol analgesia via 5-HT3 antagonism)
- CNS depressants — additive sedation
Monitoring
- Pain score
- Nausea/vomiting
- Neurological status (seizure risk, serotonin syndrome)
- Respiratory rate
Reference: BNFc; BNF; MHRA Drug Safety Update 2013 (tramadol children); RCoA Acute Pain Handbook. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- ASA Physical Status Classification · Pre-operative Risk
- Aldrete Score for Post-Anaesthesia Discharge · Post-operative
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) for Pain · Pain Assessment
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH